Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: MADHAVBAUG | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Vaidya Sane Ayur Lab

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Vaidya Sane Ayurved Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
35.77
Market Cap:
175.2 Cr.
52-wk low:
0
52-wk high:
0

Is Vaidya Sane Ayurved Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Vaidya Sane Ayur Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vaidya Sane Ayurved Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%9%4.7%7.7%22.5%19.9%3.5%12%-
Value Creation
Index
NANANA-0.4-0.7-0.50.60.4-0.8-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00062.575.252.374.79997.387.187
Sales YoY Gr.-NANANA20.4%-30.5%42.9%32.6%-1.7%-10.5%-
Adj EPS 0000.7-0.80.63.34.90.95.54.7
YoY Gr.-NANANA-212.7%NA489.3%49.7%-82.6%534.9%-
BVPS (₹) 000001434.138.839.656.856.8
Adj Net
Profit
0000.5-0.60.43.55.20.95.75
Cash Flow from Ops. 0001.67.75.8-13.3-0.43.47.6-
Debt/CF from Ops. 0005.50.80.2-0.1-0.30.50.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA3%5.3%-10.5%
Adj EPS NANA18.3%534.9%
BVPSNANA18.5%43.5%
Share Price - - -10.8% 70.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0005.7-6.64.415.213.51.9108.2
Op. Profit
Mgn %
00053.96.39.89.13.311.8NAN
Net Profit
Mgn %
0000.8-0.70.84.65.20.96.65.6
Debt to
Equity
00010.70.10000-
Working Cap
Days
00004656374466750
Cash Conv.
Cycle
0000-26-45-34-24-19-230

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Vaidya Sane Ayurved Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 4.7 6.8
TTM Sales (₹ Cr.) 87.1 89.9
BVPS (₹.) 56.8 59.5
Reserves (₹ Cr.) 49 52
P/BV 2.93 2.80
PE 35.77 24.54
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 175
Equity (₹ Cr.) 10.5
Face Value (₹) 10
Industry PE 79.6

Management X-Ray of Vaidya Sane Ayur Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vaidya Sane Ayur Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Vaidya Sane Ayur Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales62755275999787
Operating Expenses 59724967909477
Manufacturing Costs2333333
Material Costs17211722282824
Employee Cost 15211318212418
Other Costs 25271624383832
Operating Profit 33379310
Operating Profit Margin (%) 5.0%3.9%6.3%9.8%9.1%3.3%11.8%
Other Income 0000122
Interest 1111100
Depreciation 2222334
Exceptional Items 000000-1
Profit Before Tax 1-005717
Tax 0001202
Profit After Tax 0-103515
PAT Margin (%) 0.8%-0.7%0.7%4.6%5.2%1.1%5.6%
Adjusted EPS (₹)0.7-0.80.63.34.91.04.7
Dividend Payout Ratio (%)0%0%0%0%5%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 981036414260
Share Capital 00011111111
Reserves 981025303149
Minority Interest0000000
Debt9611021
Long Term Debt0000000
Short Term Debt9611021
Trade Payables6877997
Others Liabilities 57865195
Total Liabilities 29292650557174

Fixed Assets

Gross Block21232729354048
Accumulated Depreciation571012141721
Net Fixed Assets 16161717212227
CWIP 2401231
Investments 00021152526
Inventories4322332
Trade Receivables4234667
Cash Equivalents 1113222
Others Assets 33336108
Total Assets 29292650557174

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 286-13-038
PBT 1-025717
Adjustment 2322123
Changes in Working Capital -153-19-61-1
Tax Paid -0-0-1-1-3-1-1
Cash Flow From Investing Activity -10-4-1-81-17-7
Capex -9-4-1-3-7-5-7
Net Investments -000-57-10-1
Others -1-0001-22
Cash Flow From Financing Activity 8-4-522-114-1
Net Proceeds from Shares 00023000
Net Proceeds from Borrowing 0000-100
Interest Paid -1-1-0-0-0-0-0
Dividend Paid 0000-0-00
Others 8-3-5-0015-0
Net Cash Flow -10-02-100

Finance Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)5.65-6.564.3615.213.532.549.67
ROCE (%)9.044.737.6922.5319.943.512.02
Asset Turnover Ratio2.162.591.911.971.881.541.21
PAT to CFO Conversion(x)N/AN/AN/A-4.33-031.6
Working Capital Days
Receivable Days21151815182327
Inventory Days211616891211
Payable Days138124162117108115122

Vaidya Sane Ayurved Laboratories Ltd Stock News

Vaidya Sane Ayurved Laboratories Ltd FAQs

The current trading price of Vaidya Sane Ayur Lab on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vaidya Sane Ayur Lab stood at ₹175.2.
The latest P/E ratio of Vaidya Sane Ayur Lab as of 31-Dec-1969 is 35.77.
The latest P/B ratio of Vaidya Sane Ayur Lab as of 31-Dec-1969 is 2.93.
The 52-week high of Vaidya Sane Ayur Lab is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vaidya Sane Ayur Lab is ₹87.11 ( Cr.) .

About Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Ayurved Laboratories (Madhavbaug) is a unique medical service institution that strives to treat chronic ailments like cardiac disease, diabetes, hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda. The company’s approach to treatment using non-invasive, multidisciplinary and innovative therapies which has helped establish it as a dependable option for treating the chronic ailments. It is a health care provider primarily in the India’s chronic care ecosystem. It provides its healthcare services through Madhavbaug clinics. As on November 30, 2021, the company operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi and Chhattisgarh. Out of these 52 are company owned and 222 are franchise clinics. It also operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively. Currently, the company’s network includes 274 Clinics and 2 Fully equipped Hospital. 

At the company’s clinics and hospitals, it use modern diagnostics, diet and physiotherapy and advanced Ayurveda to provide Heart disease, Diabetes, Hypertension & Obesity reversal treatments to its patients. This helps in improving the exercise tolerance of patients - improvement in grade of symptoms, improvement in maximum oxygen uptake, reduction in Hba1c, and metabolic equivalents (METs).

Business area of the company

The company is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with the traditional Ayurveda practices.

Major Events and Milestones

  • 2006: First Cardiac Prevention and Rehabilitation Hospital at Khopoli and opening of first Madhavbaug Clinic at Dombivili, Maharashtra.
  • 2009: Setting up of inhouse research and development team at Thane.
  • 2012: First Cardiac Prevention and Rehabilitation Hospital at Nagpur.
  • 2013: Opening of 100th Madhavbaug Clinic at Kankavli, Ratnagiri
  • 2014: Arogyam Hriday Sampada launched with a Mission to create awareness of heart disease.
  • 2015: Launch of therapies for risk factors such as Diabetes, Obesity and Hypertension at Madhavbaug Clinics.
  • 2016: Disease wise diet kits introduced at Madhavbaug Clinics.
  • 2016: Madhavbaug Institute of Preventive Cardiology established with MUHS.
  • 2017: Entered into the state of Madhya Pradesh
  • 2017: Madhavbaug Clinics received Frost and Sullivan’s 2017 India Best Practices Award.
  • 2017: Randomised controlled trial by Madhavbaug published in Indian Heart Journal, Official publication of Cardiological Society of India.
  • 2018: Madhavbaug Clinics enters in India Book of Records for Conducting GTT of 661 diabetic patients in single day at 13 different locations.
  • 2018: Participated as main sponsor of World Ayurved Congress 2018 held at Ahmedabad.
  • 2018: Opening of 200th Madhavbaug Clinic at Nanded, Maharashtra.
  • 2018: Entered into the state of Uttar Pradesh and Gujarat.
  • 2019: Entered into the state of Delhi.
  • 2019: Madhavbaug introduced research based heart blockage management program.
  • 2019: Achieved new registrations of over 90,000 patients and more than 27,000 stress tests conducted and over 3,00,000 panchkarma procedures performed.
  • 2020: Launch of MIB Pulse Mobile Application for patient engagement.
  • 2020: Entered into the state of Karnataka
  • 2021: MIB Pulse Mobile Application achieved over 1,00,000 downloads.
  • 2021: Opening of 250th Madhavbaug Clinic at Vashi.
  • 2020: Entered into the state of Chhattisgarh.
  • 2021: Research trial on one year follow-up of Diabetes patients treated by Madhavbaug published in Journal of Association of Physicians of India.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×